[144] Reservoir Media, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Reservoir Media, Inc. (RSVR) shows a proposed sale of 34,719 common shares through Merrill Lynch on NASDAQ with an aggregate market value of $273,527.81, and lists the approximate sale date as 09/09/2025. The shares to be sold were acquired as compensation from Adam Rothstein on multiple dates between 02/11/2022 and 11/08/2024, totaling 60,069 shares acquired. The filing also discloses prior sales by the same person in August 2025: 74,558 shares sold on 08/07/2025 for $565,224.16 and 48,430 shares sold on 08/08/2025 for $361,219.68, totaling 122,988 shares and $926,443.84 in gross proceeds.

Positive

• None.

Negative

• The filer reported two recent August 2025 sales totaling 122,988 shares for aggregate gross proceeds of $926,443.84.
• A proposed sale of 34,719 shares (aggregate market value $273,527.81) is scheduled for 09/09/2025 through Merrill Lynch on NASDAQ.

Insights

Securities Analyst

TL;DR: Insider filed to sell 34,719 RSVR shares; significant prior August sales amounted to 122,988 shares for $926,443.84.

The Form 144 identifies a proposed 09/09/2025 sale of 34,719 common shares via Merrill Lynch on NASDAQ, valued at $273,527.81. Acquisition records show these shares were received as compensation from Adam Rothstein between 2022 and 2024, totaling 60,069 shares acquired. The filer also recorded two substantial August 2025 disposals totaling 122,988 shares for $926,443.84 in gross proceeds. From a securities-transaction perspective, the filing documents routine insider sales activity and the mechanics of the planned sale; it does not state any undisclosed material information.

Corporate Governance Expert

TL;DR: Disclosure is procedural and consistent with Rule 144; shows multiple compensation-based acquisitions and subsequent sales by the same person.

The notice documents that the shares to be sold were acquired as compensation and that the filer affirms no undisclosed material adverse information. The record of recent August sales and the current 09/09/2025 proposed sale provides transparency on insider dispositions. This filing is a compliance disclosure rather than a narrative about company operations; it does not include operational, financial, or governance changes beyond the insider selling activity reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 200 Varick St Suite 801 New York NY 10014	34719	273527.81	65559023	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2022	Compensation	Adam Rothstein			54700	09/09/2025	Compensation
Common	02/14/2022	Compensation	Adam Rothstein			3357	09/09/2025	Compensation
Common	07/28/2024	Compensation	Adam Rothstein			1457	09/09/2025	Compensation
Common	11/08/2024	Compensation	Adam Rothstein			555	09/09/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Rothstein 200 Varick St Suite 801 New York NY 10014	Common	08/07/2025	74558	565224.16
Adam Rothstein 200 Varick St Suite 801 New York NY 10014	Common	08/08/2025	48430	361219.68

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)